bromodeoxyuridine has been researched along with imatinib mesylate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gendron, MC; Goria, O; Housset, C; Kinnman, N; Poupon, R; Rey, C; Wendum, D | 1 |
| Han, MK; Horowitz, JC; Moore, BB; Thannickal, VJ; Vittal, R; Zhang, H | 1 |
| Cao, Y; Elmi, M; Fujimori, T; Funa, K; Ishii, Y; Matsumoto, Y; Nabeshima, Y; Nissen, J; Sasahara, M; Watanabe, R | 1 |
| Aktas, E; Bilir, A; Bonavida, B; Erguven, M; Oktem, G; Ozdemir, A; Uslu, A | 1 |
| Belcastro, R; Lau, M; Li, J; Masood, A; Tanswell, AK; Yi, M | 1 |
| Cui, MM; Fu, PY; Huang, L; Liu, X; Wang, GC; Zhu, HZ | 1 |
6 other study(ies) available for bromodeoxyuridine and imatinib mesylate
| Article | Year |
|---|---|
Hepatic stellate cell proliferation is an early platelet-derived growth factor-mediated cellular event in rat cholestatic liver injury.
Topics: Actins; Animals; Benzamides; Bromodeoxyuridine; Cell Division; Cholestasis; Enzyme Inhibitors; Imatinib Mesylate; Liver; Male; Muscle, Smooth; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor beta; Time Factors; Up-Regulation | 2001 |
Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseases.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Benzamides; Bleomycin; Blotting, Western; Bromodeoxyuridine; Caspase 3; Cell Line, Tumor; Cells, Cultured; Collagen; DNA, Single-Stranded; Dose-Response Relationship, Drug; Epithelial Cells; Fibroblasts; Fibrosis; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Indicators and Reagents; Injections, Intraperitoneal; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases; Mesenchymal Stem Cells; Mice; Phenotype; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction | 2007 |
Characterization of neuroprogenitor cells expressing the PDGF beta-receptor within the subventricular zone of postnatal mice.
Topics: Analysis of Variance; Animals; Animals, Newborn; Benzamides; Bromodeoxyuridine; Cell Differentiation; Cell Movement; Cells, Cultured; Enzyme Inhibitors; Gene Expression; Imatinib Mesylate; Intermediate Filament Proteins; Ki-67 Antigen; Lateral Ventricles; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Tissue Proteins; Nestin; Neurons; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Stem Cells; Transfection | 2008 |
Potentiation of cytotoxicity by combination of imatinib and chlorimipramine in glioma.
Topics: Animals; Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Clomipramine; Cyclic AMP; Drug Synergism; Glioma; Imatinib Mesylate; Microscopy, Electron, Scanning; Piperazines; Pyrimidines; Rats | 2008 |
Long-term failure of alveologenesis after an early short-term exposure to a PDGF-receptor antagonist.
Topics: Animals; Animals, Newborn; Benzamides; Blotting, Western; Body Weight; Bromodeoxyuridine; Cell Count; Densitometry; Elastin; Imatinib Mesylate; Organ Size; Organogenesis; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-kit; Pulmonary Alveoli; Pyrimidines; Rats; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Time Factors | 2011 |
MiR-199a-3p Overexpression Suppressed Cell Proliferation and Sensitized Chronic Myeloid Leukaemia Cells to Imatinib by Inhibiting mTOR Signalling.
Topics: Apoptosis; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Luciferases; MicroRNAs; Protein-Tyrosine Kinases; TOR Serine-Threonine Kinases | 2022 |